4//SEC Filing
Brunn Carsten 4
Accession 0001453687-23-000088
CIK 0001453687other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:26 PM ET
Size
30.6 KB
Accession
0001453687-23-000088
Insider Transaction Report
Form 4
Brunn Carsten
DirectorPresident and CEO
Transactions
- Disposition to Issuer
Common Stock
2023-11-13$2.06/sh−55,000$113,300→ 728,081 total - Disposition to Issuer
Common Stock
2023-11-13$2.06/sh−13,600$28,016→ 714,481 total - Disposition to Issuer
Common Stock
2023-11-13$2.06/sh−169,725$349,634→ 544,756 total - Disposition to Issuer
Common Stock
2023-11-13$2.06/sh−282,800$582,568→ 261,956 total - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−1,000,000→ 0 totalExercise: $6.03Exp: 2028-11-30→ Common Stock (1,000,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−330,000→ 0 totalExercise: $2.20Exp: 2029-02-24→ Common Stock (330,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13$0.31/sh−400,000$124,000→ 0 totalExercise: $1.75Exp: 2029-10-06→ Common Stock (400,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−600,000→ 0 totalExercise: $2.30Exp: 2030-01-01→ Common Stock (600,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−75,000→ 0 totalExercise: $2.84Exp: 2030-06-30→ Common Stock (75,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−670,000→ 0 totalExercise: $2.99Exp: 2031-01-03→ Common Stock (670,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−163,000→ 0 totalExercise: $4.32Exp: 2031-09-23→ Common Stock (163,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13−1,056,100→ 0 totalExercise: $3.31Exp: 2032-01-02→ Common Stock (1,056,100 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-11-13$0.93/sh−1,275,000$1,185,750→ 0 totalExercise: $1.13Exp: 2033-01-01→ Common Stock (1,275,000 underlying)
Footnotes (13)
- [F1]This unvested restricted stock, which was granted on January 4, 2021, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc., in exchange for $113,300, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
- [F10]This option, which provided for vesting as to 25% of the shares on January 4, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F11]This option, which provided for vesting as to 25% of the shares on September 24, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F12]This option, which provided for vesting as to 25% of the shares on January 3, 2023 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F13]This option, which provided for vesting as to 25% of the shares on January 2, 2024 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger, in exchange for a cash payment of $1,185,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
- [F2]This unvested restricted stock, which was granted on September 24, 2021, was canceled in the Merger, in exchange for $28,016, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
- [F3]This unvested restricted stock, which was granted on January 3, 2022, was canceled in the Merger, in exchange for $349,633.50, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
- [F4]This unvested restricted stock, which was granted on January 2, 2023, was canceled in the Merger, in exchange for $582,568, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
- [F5]This option, which provided for vesting as to 25% of the shares on December 1, 2019 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F6]This option, which provided for vesting as to 25% of the shares on February 25, 2020 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F7]This option, which provided for vesting as to 50% of the shares on October 7, 2020 and the remaining 50% of the shares on October 7, 2021, was canceled in the Merger, in exchange for a cash payment of $124,000, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
- [F8]This option, which provided for vesting as to 25% of the shares on January 2, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
- [F9]This option, which provided for vesting as to 25% of the shares on July 1, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0001760229
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:26 PM ET
- Size
- 30.6 KB